Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial

JAMA

Volumn 283, Issue 12, 2000, Pages 1583-1590

  Talan, David A ^a   Stamm, Walter E ^b,c   Hooton, Thomas M ^b,c   Moran, Gregory J ^a   Burke, Thomas ^b   Iravani, Abdollah ^e   Reuning Scherer, Jonathan ^d   Church, Deborah A ^d  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BAYER CORPORATION   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE;

ACUTE PYELONEPHRITIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MULTICENTER STUDY; NAUSEA; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING; VERTIGO; VOMITING;

EID: 0034701178     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.12.1583     Document Type: Article

References (31)

1. Stamm WE, Hooton TM, Johnson JR, et al. Urinary tract infections. J Infect Dis. 1989;15:400-406.
2. McCarthy E. Inpatient Utilization of Short-Stay Hospitals, by Diagnosis: United States-1980. Hyattsville, Md: National Center for Health Statistics; 1989. DHHS publication 83-1735.
3. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis. 1990;12:458-467.
4. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329: 1328-1334.
5. Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA. 1995;273:41-45.
6. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736-738.
7. Approved Standard: Performance Standards for Antimicrobial Disk Susceptibility Tests. 4th ed, Villanova, Pa: National Committee for Clinical Laboratory Standards; 1993.
8. Approved Standard: Methods for Dilution in Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 2nd ed. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1993.
9. 1997 Drug Topics Redbook. Montvale, NJ: Mediv cal Economics Co Inc; 1997.
10. American Hospital Association. Hospital Statistics. Chicago, III: American Hospital Association; 1995.
11. Consumer Price Index for Medical Care Services. Washington, DC: Bureau of Labor Statistics; 1997.
12. Physicians' Current Procedural Terminology CPT 1998: Professional Edition. Chicago, III: American Medical Association; 1997.
13. Segal MJ, Heald RB, eds. Medicare RBRVS: The Physician's Guide. Chicago, III: American Medical Association, 1995.
14. Appendix D: revised laboratory RVU list. In: Accounting and Budget Manual for Fiscal and Operating Management, Revision #23. Baltimore: State of Maryland Health Services Cost Review Commission; 1996.
15. Current Rates Report. Baltimore: State of Maryland Health Services Cost Review Commission; 1998.
16. Points to Consider. Rockville, Md: US Food and Drug Administration; 1992:20.
17. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial therapy of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29:745-758.
18. Johnson JR, Lyons MF II, Pearce W, et al. Therapy for women hospitalized with acute pyelonephritis. J Infect Dis. 1991;163:325-330.
19. Stamm WE, McKevitt M, Counts GW. Acute renal infection in women. Ann Intern Med. 1987;106:341-345.
20. Safrin S, Siegel D, Black D. Pyelonephritis in adult women. Am J Med. 1988;85:793-798.
21. Abraham E, Baraff LJ. Oral versus parenteral therapy of pyelonephritis. Curr Ther Res 1982;31: 536-542.
22. Ward G, Jorden RC, Severance HW. Treatment of pyelonephritis in an observation unit. Ann Emerg Med. 1991;20:258-261.
23. Bailey RR, Lynn KL, Robson RA, Peddie BA, Smith A. Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. N Z Med J. 1992; 105:102-103.
24. Jernelius H, Zbornik J, Bauer C-A. One or three week's treatment of acute pyelonephritis? Acta Med Scand. 1988;233:469-477.
25. Gleckman R, Bradley P, Roth R, Hibert D, Pelletier C. Therapy of symptomatic pyelonephritis in women. J Urol. 1985;133:176-178.
26. Ode B, Bröms M, Walder M, Cronberg S. Failure of excessive doses of ampicillin to prevent bacterial relapse in the treatment of acute pyelonephritis. Acta Med Scand. 1980;207:305-307.
27. Beunders AJ. Development of antibacterial resistance: the Dutch experience. J Antimicrob Chemother. 1994;33(suppl A):S17-S22.
28. Alon U, Davidai G, Berant M, Merzbach D. Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprimsulfamethoxazole and other antimicrobial agents. Antimicrob Agents Chemother. 1987;31:126-128.
29. Winstanley TG, Limb Dl, Eggington R, Hancock F. A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J Antimicrob Chemother. 1997;40:591-594.
30. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551-581.
31. Rubin RR, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis. 1992;15(suppl 1):S216-S227.